##gff-version 3
##sequence-region Q9Y6K9 1 419
Q9Y6K9	UniProtKB	Chain	1	419	.	.	.	ID=PRO_0000096782;Note=NF-kappa-B essential modulator	
Q9Y6K9	UniProtKB	Zinc finger	389	419	.	.	.	Note=CCHC NOA-type;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU01142	
Q9Y6K9	UniProtKB	Region	44	111	.	.	.	Note=Interaction with CHUK/IKBKB	
Q9Y6K9	UniProtKB	Region	150	257	.	.	.	Note=Interaction with TANK	
Q9Y6K9	UniProtKB	Region	242	350	.	.	.	Note=Ubiquitin-binding (UBD)	
Q9Y6K9	UniProtKB	Region	246	365	.	.	.	Note=Self-association	
Q9Y6K9	UniProtKB	Region	251	419	.	.	.	Note=Required for interaction with TNFAIP3	
Q9Y6K9	UniProtKB	Region	322	343	.	.	.	Note=Leucine-zipper;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9Y6K9	UniProtKB	Region	382	419	.	.	.	Note=Interaction with CYLD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12917691;Dbxref=PMID:12917691	
Q9Y6K9	UniProtKB	Coiled coil	49	356	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9Y6K9	UniProtKB	Modified residue	31	31	.	.	.	Note=Phosphoserine%3B by IKKB;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12657630;Dbxref=PMID:12657630	
Q9Y6K9	UniProtKB	Modified residue	43	43	.	.	.	Note=Phosphoserine%3B by IKKB;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12657630;Dbxref=PMID:12657630	
Q9Y6K9	UniProtKB	Modified residue	68	68	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17977820;Dbxref=PMID:17977820	
Q9Y6K9	UniProtKB	Modified residue	85	85	.	.	.	Note=Phosphoserine%3B by ATM;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16497931;Dbxref=PMID:16497931	
Q9Y6K9	UniProtKB	Modified residue	376	376	.	.	.	Note=Phosphoserine%3B by IKKB;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12657630;Dbxref=PMID:12657630	
Q9Y6K9	UniProtKB	Modified residue	387	387	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:24275569,ECO:0000269|PubMed:24012789;Dbxref=PMID:24275569,PMID:24012789	
Q9Y6K9	UniProtKB	Disulfide bond	54	54	.	.	.	Note=Interchain;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18164680;Dbxref=PMID:18164680	
Q9Y6K9	UniProtKB	Disulfide bond	347	347	.	.	.	Note=Interchain;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18164680;Dbxref=PMID:18164680	
Q9Y6K9	UniProtKB	Cross-link	111	111	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21455181;Dbxref=PMID:21455181	
Q9Y6K9	UniProtKB	Cross-link	139	139	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21455181;Dbxref=PMID:21455181	
Q9Y6K9	UniProtKB	Cross-link	143	143	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21455181;Dbxref=PMID:21455181	
Q9Y6K9	UniProtKB	Cross-link	226	226	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21455181;Dbxref=PMID:21455181	
Q9Y6K9	UniProtKB	Cross-link	246	246	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21455181;Dbxref=PMID:21455181	
Q9Y6K9	UniProtKB	Cross-link	264	264	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21455181;Dbxref=PMID:21455181	
Q9Y6K9	UniProtKB	Cross-link	277	277	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14651848;Dbxref=PMID:14651848	
Q9Y6K9	UniProtKB	Cross-link	277	277	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)%3B alternate;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14651848,ECO:0000269|PubMed:21455181;Dbxref=PMID:14651848,PMID:21455181	
Q9Y6K9	UniProtKB	Cross-link	283	283	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21455181;Dbxref=PMID:21455181	
Q9Y6K9	UniProtKB	Cross-link	285	285	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15620648,ECO:0000269|PubMed:19136968,ECO:0000269|PubMed:21455181;Dbxref=PMID:15620648,PMID:19136968,PMID:21455181	
Q9Y6K9	UniProtKB	Cross-link	292	292	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21455181;Dbxref=PMID:21455181	
Q9Y6K9	UniProtKB	Cross-link	302	302	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21455181;Dbxref=PMID:21455181	
Q9Y6K9	UniProtKB	Cross-link	309	309	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14651848;Dbxref=PMID:14651848	
Q9Y6K9	UniProtKB	Cross-link	309	309	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)%3B alternate;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14651848,ECO:0000269|PubMed:19136968,ECO:0000269|PubMed:20010814,ECO:0000269|PubMed:21455181;Dbxref=PMID:14651848,PMID:19136968,PMID:20010814,PMID:21455181	
Q9Y6K9	UniProtKB	Cross-link	321	321	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20010814;Dbxref=PMID:20010814	
Q9Y6K9	UniProtKB	Cross-link	325	325	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O88522	
Q9Y6K9	UniProtKB	Cross-link	326	326	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21455181;Dbxref=PMID:21455181	
Q9Y6K9	UniProtKB	Cross-link	399	399	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14695475;Dbxref=PMID:14695475	
Q9Y6K9	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_041000;Note=In isoform 2. M->MALVIQVGKLRPREVRTPQTINPSLFPSLPVKLSSIIEVPSGGERCCSRRTLVYKARAFWKGAPLPCWM;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.6	
Q9Y6K9	UniProtKB	Alternative sequence	174	224	.	.	.	ID=VSP_041001;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q9Y6K9	UniProtKB	Alternative sequence	257	304	.	.	.	ID=VSP_041002;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q9Y6K9	UniProtKB	Natural variant	57	57	.	.	.	ID=VAR_026491;Note=In IP%3B shows the same luciferase activity as the control. E->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11590134,ECO:0000269|PubMed:15229184;Dbxref=dbSNP:rs148695964,PMID:11590134,PMID:15229184	
Q9Y6K9	UniProtKB	Natural variant	90	90	.	.	.	ID=VAR_026492;Note=In IP%3B only 46.3%25 of the activation obtained with the wild-type protein. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15229184;Dbxref=PMID:15229184	
Q9Y6K9	UniProtKB	Natural variant	113	113	.	.	.	ID=VAR_026493;Note=D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15229184;Dbxref=dbSNP:rs179363896,PMID:15229184	
Q9Y6K9	UniProtKB	Natural variant	123	123	.	.	.	ID=VAR_026494;Note=In IP%3B shows the same luciferase activity as the control. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15229184;Dbxref=dbSNP:rs179363895,PMID:15229184	
Q9Y6K9	UniProtKB	Natural variant	153	153	.	.	.	ID=VAR_026495;Note=In EDAID. L->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12045264,ECO:0000269|PubMed:15100680;Dbxref=dbSNP:rs137853328,PMID:12045264,PMID:15100680	
Q9Y6K9	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_072603;Note=In IP. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24339369;Dbxref=PMID:24339369	
Q9Y6K9	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_031958;Note=In IPD2. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16950813;Dbxref=dbSNP:rs179363866,PMID:16950813	
Q9Y6K9	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_072604;Note=In IP. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24339369;Dbxref=PMID:24339369	
Q9Y6K9	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_011320;Note=In EDAID. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11242109;Dbxref=dbSNP:rs179363868,PMID:11242109	
Q9Y6K9	UniProtKB	Natural variant	183	183	.	.	.	ID=VAR_072605;Note=In IP. Q->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20434027;Dbxref=dbSNP:rs1198984417,PMID:20434027	
Q9Y6K9	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_011321;Note=In EDAID. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11242109;Dbxref=dbSNP:rs179363869,PMID:11242109	
Q9Y6K9	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_011322;Note=In EDAID. A->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11242109;Dbxref=dbSNP:rs137853330,PMID:11242109	
Q9Y6K9	UniProtKB	Natural variant	311	311	.	.	.	ID=VAR_011323;Note=In EDAID%3B abolishes binding to polyubiquitin ('K63'-linked and linear) and greatly impairs tandem ubiquitin binding. D->N;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11242109,ECO:0000269|PubMed:16547522,ECO:0000269|PubMed:19185524,ECO:0000269|PubMed:21606507;Dbxref=dbSNP:rs179363867,PMID:11242109,PMID:16547522,PMID:19185524,PMID:21606507	
Q9Y6K9	UniProtKB	Natural variant	314	314	.	.	.	ID=VAR_072606;Note=In IP. A->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24339369;Dbxref=PMID:24339369	
Q9Y6K9	UniProtKB	Natural variant	315	315	.	.	.	ID=VAR_031959;Note=In IMD33%3B greatly impairs tandem ubiquitin binding. Impairs oligomerization%2C impairs binding of 'Lys-63'-linked ubiuitin and linear tetra-ubiquitin%2C impairs TNF-induced NF-kappa-B activation. E->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16818673,ECO:0000269|PubMed:19185524,ECO:0000269|PubMed:19854204;Dbxref=dbSNP:rs137853331,PMID:16818673,PMID:19185524,PMID:19854204	
Q9Y6K9	UniProtKB	Natural variant	319	319	.	.	.	ID=VAR_031960;Note=In IMD33%3B impairs tandem ubiquitin binding. R->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16818673,ECO:0000269|PubMed:19185524;Dbxref=dbSNP:rs137853332,PMID:16818673,PMID:19185524	
Q9Y6K9	UniProtKB	Natural variant	322	322	.	.	.	ID=VAR_072607;Note=In IP. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24339369;Dbxref=PMID:24339369	
Q9Y6K9	UniProtKB	Natural variant	323	323	.	.	.	ID=VAR_042666;Note=In IP%3B diminishes interaction with TRAF6 and polyubiquitination%2C greatly impairs tandem ubiquitin binding. Impairs oligomerization%2C greatly impairs binding of 'Lys-63'-linked ubiuitin and linear tetra-ubiquitin%2C impairs TNF-induced NF-kappa-B activation. A->P;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17728323,ECO:0000269|PubMed:19185524,ECO:0000269|PubMed:19854204;Dbxref=dbSNP:rs179363865,PMID:17728323,PMID:19185524,PMID:19854204	
Q9Y6K9	UniProtKB	Natural variant	406	406	.	.	.	ID=VAR_011324;Note=In EDAID. D->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11224521;Dbxref=dbSNP:rs137853327,PMID:11224521	
Q9Y6K9	UniProtKB	Natural variant	407	407	.	.	.	ID=VAR_009182;Note=In IP%3B impairs binding to ubiquitin. M->V;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10839543,ECO:0000269|PubMed:11590134,ECO:0000269|PubMed:19033441;Dbxref=dbSNP:rs137853322,PMID:10839543,PMID:11590134,PMID:19033441	
Q9Y6K9	UniProtKB	Natural variant	413	413	.	.	.	ID=VAR_072608;Note=In IP. H->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24339369;Dbxref=PMID:24339369	
Q9Y6K9	UniProtKB	Natural variant	417	417	.	.	.	ID=VAR_011325;Note=In EDAID. C->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11047757,ECO:0000269|PubMed:11242109;Dbxref=dbSNP:rs137853326,PMID:11047757,PMID:11242109	
Q9Y6K9	UniProtKB	Natural variant	417	417	.	.	.	ID=VAR_011326;Note=In EDAID%3B loss of sumoylation. C->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11047757,ECO:0000269|PubMed:11224521,ECO:0000269|PubMed:11242109,ECO:0000269|PubMed:12045264,ECO:0000269|PubMed:14651848,ECO:0000269|PubMed:15100680;Dbxref=dbSNP:rs137853325,PMID:11047757,PMID:11224521,PMID:11242109,PMID:12045264,PMID:14651848,PMID:15100680	
Q9Y6K9	UniProtKB	Natural variant	417	417	.	.	.	ID=VAR_026496;Note=In NEMOID. C->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15100680;Dbxref=dbSNP:rs137853326,PMID:15100680	
Q9Y6K9	UniProtKB	Mutagenesis	68	68	.	.	.	Note=Increases formation of homodimers. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17977820;Dbxref=PMID:17977820	
Q9Y6K9	UniProtKB	Mutagenesis	68	68	.	.	.	Note=Abolishes interaction with IKBKB%3B abolishes TNF-alpha induced NF-kappa-B activity. S->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17977820;Dbxref=PMID:17977820	
Q9Y6K9	UniProtKB	Mutagenesis	85	85	.	.	.	Note=Decreases ubiquitination and abolishes nuclear export. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16497931;Dbxref=PMID:16497931	
Q9Y6K9	UniProtKB	Mutagenesis	115	115	.	.	.	Note=No change in the ubiquitination level%3B when associated with R-399. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15620648;Dbxref=PMID:15620648	
Q9Y6K9	UniProtKB	Mutagenesis	224	224	.	.	.	Note=No change in the ubiquitination level%3B when associated with R-399. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15620648;Dbxref=PMID:15620648	
Q9Y6K9	UniProtKB	Mutagenesis	277	277	.	.	.	Note=Partial abolition of sumoylation. Abolishes sumoylation and IKK activation%3B when associated with A-309. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14651848;Dbxref=PMID:14651848	
Q9Y6K9	UniProtKB	Mutagenesis	285	285	.	.	.	Note=Important decrease in the ubiquitination level%3B when associated with R-399. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15620648;Dbxref=PMID:15620648	
Q9Y6K9	UniProtKB	Mutagenesis	296	296	.	.	.	Note=No effet on oligomerization%2Cimpairs binding of 'Lys-63'-linked ubiuitin and linear tetra-ubiquitin%2C impairs TNF-induced NF-kappa-B activation. E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19854204;Dbxref=PMID:19854204	
Q9Y6K9	UniProtKB	Mutagenesis	300	300	.	.	.	Note=Greatly impairs tandem ubiquitin binding. V->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19185524;Dbxref=PMID:19185524	
Q9Y6K9	UniProtKB	Mutagenesis	301	301	.	.	.	Note=Impairs tandem ubiquitin binding. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19185524;Dbxref=PMID:19185524	
Q9Y6K9	UniProtKB	Mutagenesis	304	304	.	.	.	Note=Complete loss of cleavage by HAV protease 3c. Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24920812;Dbxref=PMID:24920812	
Q9Y6K9	UniProtKB	Mutagenesis	304	304	.	.	.	Note=Impairs tandem ubiquitin binding. Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19185524;Dbxref=PMID:19185524	
Q9Y6K9	UniProtKB	Mutagenesis	307	307	.	.	.	Note=Greatly impairs tandem ubiquitin binding. I->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19185524;Dbxref=PMID:19185524	
Q9Y6K9	UniProtKB	Mutagenesis	308	308	.	.	.	Note=Greatly impairs tandem ubiquitin binding. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19185524;Dbxref=PMID:19185524	
Q9Y6K9	UniProtKB	Mutagenesis	309	309	.	.	.	Note=Partial abolition of sumoylation. Abolishes sumoylation and IKK activation%3B when associated with A-277. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14651848;Dbxref=PMID:14651848	
Q9Y6K9	UniProtKB	Mutagenesis	312	312	.	.	.	Note=Greatly impairs tandem ubiquitin binding%2Cimpairs oligomerization%2C impairs TNF-induced NF-kappa-B activation. F->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19185524,ECO:0000269|PubMed:19854204;Dbxref=PMID:19185524,PMID:19854204	
Q9Y6K9	UniProtKB	Mutagenesis	312	312	.	.	.	Note=MNo effet on oligomerization%2C preferentially binds tri-ubiquitin chains ('Lys-48' or 'Lys-63'-linked). F->W;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19185524,ECO:0000269|PubMed:19854204;Dbxref=PMID:19185524,PMID:19854204	
Q9Y6K9	UniProtKB	Mutagenesis	312	312	.	.	.	Note=Impairs tandem ubiquitin binding. F->Y;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19185524,ECO:0000269|PubMed:19854204;Dbxref=PMID:19185524,PMID:19854204	
Q9Y6K9	UniProtKB	Mutagenesis	313	313	.	.	.	Note=Impairs tandem ubiquitin binding. Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19185524;Dbxref=PMID:19185524	
Q9Y6K9	UniProtKB	Mutagenesis	315	315	.	.	.	Note=Greatly impairs tandem ubiquitin binding. E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19854204;Dbxref=PMID:19854204	
Q9Y6K9	UniProtKB	Mutagenesis	317	317	.	.	.	Note=Greatly impairs tandem ubiquitin binding. Q->A%2CW;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19185524;Dbxref=PMID:19185524	
Q9Y6K9	UniProtKB	Mutagenesis	323	323	.	.	.	Note=Greatly impairs tandem ubiquitin binding. A->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19854204;Dbxref=PMID:19854204	
Q9Y6K9	UniProtKB	Mutagenesis	329	329	.	.	.	Note=Impairs oligomerization%2C impairs binding of 'Lys-63'-linked ubiuitin%2C impairs TNF-induced NF-kappa-B activation%3B when associated with A-336. L->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16547522,ECO:0000269|PubMed:19854204;Dbxref=PMID:16547522,PMID:19854204	
Q9Y6K9	UniProtKB	Mutagenesis	329	329	.	.	.	Note=Abolishes binding to polyubiquitin. L->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16547522,ECO:0000269|PubMed:19854204;Dbxref=PMID:16547522,PMID:19854204	
Q9Y6K9	UniProtKB	Mutagenesis	336	336	.	.	.	Note=Impairs oligomerization%2C impairs binding of 'Lys-63'-linked ubiuitin%2C impairs TNF-induced NF-kappa-B activation%3B when associated with A-329. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19854204;Dbxref=PMID:19854204	
Q9Y6K9	UniProtKB	Mutagenesis	399	399	.	.	.	Note=Abolishes BCL10-mediated but not RIPK2-mediated ubiquitination. Important decrease in the ubiquitination level%3B when associated with R-285. No change in the ubiquitination level%3B when associated with R-115 or R-224. K->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14695475,ECO:0000269|PubMed:15620648;Dbxref=PMID:14695475,PMID:15620648	
Q9Y6K9	UniProtKB	Mutagenesis	414	414	.	.	.	Note=Abolishes binding to polyubiquitin. V->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19033441;Dbxref=PMID:19033441	
Q9Y6K9	UniProtKB	Mutagenesis	415	415	.	.	.	Note=Impairs binding to polyubiquitin. M->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19033441;Dbxref=PMID:19033441	
Q9Y6K9	UniProtKB	Sequence conflict	341	341	.	.	.	Note=S->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9Y6K9	UniProtKB	Sequence conflict	387	387	.	.	.	Note=S->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9Y6K9	UniProtKB	Helix	50	108	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3BRV	
Q9Y6K9	UniProtKB	Turn	194	196	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3CL3	
Q9Y6K9	UniProtKB	Helix	197	249	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3CL3	
Q9Y6K9	UniProtKB	Helix	260	268	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4BWN	
Q9Y6K9	UniProtKB	Helix	271	295	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4BWN	
Q9Y6K9	UniProtKB	Helix	297	341	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4BWN	
Q9Y6K9	UniProtKB	Beta strand	394	396	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2JVY	
Q9Y6K9	UniProtKB	Turn	398	400	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5AAY	
Q9Y6K9	UniProtKB	Beta strand	403	406	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2JVX	
Q9Y6K9	UniProtKB	Helix	407	416	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2JVX	
